• US: +1 9176726599
  • Login

Embolic Protection Devices Market Status (2016-2020) and Forecast Market Analysis, Regional Outlook, Segment Growth Potential, and Competitive Market Share Analysis, 2021-2027

Format: PDF | Pages: 308 | Report ID: MRS1133


Report Description

The global Embolic Protection Devices market size is estimated at USD 980.4 million in 2020, expanding at a CAGR 8.8% from 2021-2027 to reach 1,400.8 million USD in 2027.

Market Dynamics

Embolic protection devices (EPDs) are the most common type of device used during percutaneous cardiac procedures. The use of embolic protection devices (EPD) during percutaneous cardiac procedures has helped to reduce the number of complications caused by debris entering the bloodstream and clogging smaller vessels. These devices are a component of the most effective, scientifically proven treatment for preventing periprocedural myocardial infarction and other major cardiovascular events. Depending on their mechanism of action, EPDs are classified as distal occlusion aspiration devices, distal filters, or proximal occlusion aspiration devices.

One of the key factors driving the market growth is the rising prevalence of cardiovascular diseases (CVDs). EPDs are critical in reducing complications caused by blockages in small blood vessels caused by debris in the bloodstream. They are a component of the most dependable, evidence-based procedure for lowering periprocedural MI and other major cardiovascular events. This, combined with an increase in cardiac arrests and other heart-related issues, is providing a significant boost to the EPD market. Furthermore, governments around the world are investing in expanding their research and development (R&D) capabilities, which is another major growth-inducing factor.

The world's steadily growing geriatric population, which is more vulnerable to chronic medical illnesses, is also contributing to market growth. Other factors that are expected to contribute to the market's positive outlook include rising demand for minimally invasive products, technological advancements, and significant growth in the healthcare sector.

Regional Insights

Over the course of the study, the market for embolic protection devices in North America will grow by around 10%. The rising prevalence of cardiovascular and neurovascular diseases in the region is a major factor driving the growth of the embolic protection devices market in the coming years. Obesity prevalence, lifestyle patterns, and unhealthy dietary habits will all have a positive impact on regional market growth. The strong foothold of major industry players in North America will further boost the growth of the embolic protection devices industry.

In 2020, the Asia Pacific was growing due to a rapidly aging population, which is predisposed to various neurological, cardiovascular, and other chronic diseases that can be attributed to regional growth. The region's urbanization, changing lifestyle, and rising prevalence of risk factors such as obesity and hypertension will favor segmental growth. Increasing government support and healthcare reforms in countries such as China will drive growth in the Asia Pacific embolic protection devices industry in the coming years.

Segment Insights

The Embolic Protection Devices market is fragmented into product, application, procedure, usage, material and end-user segments. Based on the product, the proximal occlusion systems segment is anticipated to dominate the market. Based on application, the cardiovascular segment is expected to witness the highest CAGR. By material, Nitinol will exhibit substantial growth during the analysis period. By end-user, the hospitals' segment exhibits momentous growth over the forecast timeline.

Competitive Insights

The Embolic Protection Devices market is highly competitive in nature with the presence of local & international players. Major players in the industry engage in strategic mergers & acquisitions, partnerships, and new product launches to remain competent in the market.

The competitive landscape of the industry has also been examined with some of the key players being Abbott Laboratories, Allium Medical Solutions Ltd., Boston Scientific Corporation, Cardinal Health Inc., Contego Medical LLC, Innovative Cardiovascular Solutions LLC, Edwards Lifesciences Corporation, Medtronic Inc., Silk Road Medical Inc., etc.

The report begins with an overview of the Industry Chain structure, and describes the industry environment, then analyses the market size and forecast of Embolic Protection Devices by product, application, procedure, material, usage, end-user, and region. In addition, this report introduces the market competition situation among the vendors, and the company profile, besides, market price analysis, and value chain features are covered in this report.

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):

  • Abbott Laboratories
  • Allium Medical Solutions Ltd.
  • Boston Scientific Corporation
  • Cardinal Health Inc.
  • Contego Medical LLC
  • Innovative Cardiovascular Solutions LLC
  • Edwards Lifesciences Corporation
  • Medtronic Inc.
  • Silk Road Medical Inc.

Product Coverage (Market Size & Forecast, Main Consumer Analysis etc.):

  • Non-invasive
  • Minimally Invasive
  • Topical

Application Coverage (Market Size & Forecast, Main Consumer Analysis etc.):

  • Coronary Artery Treatment
  • Carotid Artery Treatment   
  • Others

Procedure Coverage (Market Size & Forecast, Main Consumer Analysis etc.):

  • Percutaneous Coronary Intervention
  • Carotid Artery Stenosis
  • Saphenous Vein Graft Intervention
  • Aortic Valve Stenosis
  • Others

Material Coverage (Market Size & Forecast, Main Consumer Analysis etc.):

  • Nitinol
  • Polyurethane

Usage Coverage (Market Size & Forecast, Main Consumer Analysis etc.):

  • Disposable Devices
  • Re-Usable Devices

End User Coverage (Market Size & Forecast, Main Consumer Analysis etc.):

  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Others

Region Coverage (Regional Consumption, Demand & Forecast by Countries etc.):

  • North America (U.S., and Canada)
  • Europe (Germany, U.K., France, Italy, Spain etc.)
  • Asia-Pacific (China, India, Japan, Indonesia, Malaysia, Australia, South Korea, etc.)
  • South America (Brazil, Mexico, Argentina etc.)
  • Middle East & Africa (Saudi Arabia, Kuwait, UAE, South Africa etc.)

Frequently Asked Questions

The global Embolic Protection Devices market size is estimated at USD 980.4 million in 2020, expanding at a CAGR 8.8% from 2021-2027 to reach 1,400.8 million USD in 2027.
North America captured the highest revenue in 2021 and is projected to continue its dominance during the study period.
The global Embolic Protection Devices market size is expanding at a CAGR 8.8% from 2021-2027 to reach 1,400.8 million USD in 2027.
Asia Pacific (especially China, and India) region is projected to grow at the fastest growth rate during the study period.
The Embolic Protection Devices market is highly competitive in nature with the presence of local & international players. Major players in the industry engage in strategic merger & acquisition, partnership, and new product launches to remain competent in the market.

Why Choose Market Research Strategy?

  Authenticated Data Sources

We utilize market analysis/information from verified authenticated data sources to scoop accurate research reports

  Express Delivery

We understand the urgency of our clients and their clients' in the competitive space thus, deliver the report in minimum turnaround

  Gain Instant Access

Without further ado, choose us and get instant access to reliable analysis to help you make the right business decisions.

  Our Pledge to You

We abide by the information security policy and adheres to keep your private and business information confidential and secure.

Copyright © 2022 Market Research Strategy, All rights reserved.